ARTICLE | Company News
CeNeS deal
February 11, 2008 8:00 AM UTC
CeNeS is in discussions with an undisclosed potential acquirer. CeNeS's M6G, a morphine-6-glucoronide (M6G) metabolite of morphine, is in Phase III testing to treat postoperative pain. At June 30, 20...